SEC Form 4 · accession 0001123292-15-001457
FIVE PRIME THERAPEUTICS INC · FPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lewis T Williams
Officer — President and CEO · Director
Period of report
Dec 24, 2015
Accepted (ET)
Dec 28, 2015 · 5:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175505
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 24, 2015 | G | 953 | $0.00 | D | 340,303 | D | |
| Common StockF1 | holding | — | — | — | 340,352 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 49 shares granted to the reporting person by the Issuer pursuant to a company match under the Issuer's 401(k) plan.